|
Swiss TPH News, October 2024 |
|
|
Defining the Research Agenda for Noma |
|
Noma is a severe disease predominantly affecting children living in extreme poverty, with a mortality rate up to 90% if left untreated. Key aspects of the disease, such as its progression and prevalence, are still unknown. At the end of last year, the World Health Organization recognised noma as a neglected tropical disease. Building on this momentum of increased global recognition, Swiss TPH organised a symposium on 20 September that brought together around 100 scientists, public health experts, politicians, health advocates and noma survivors to establish a clear research agenda to fill knowledge gaps and develop effective strategies to combat the disease. » Read more |
|
|
|
Malaria RDTs Improve Child Survival in Sub-Saharan Africa |
|
A study by Swiss TPH and the Harvard T.H. Chan School of Public Health found that distributing rapid diagnostic tests (RDTs) for malaria reduced mortality in children under five with fever in sub-Saharan Africa, comparable to other malaria interventions. Higher RDT coverage led to more blood testing and antimalarial drug use. However, in low-malaria areas, RDTs were associated with increased antibiotic use, highlighting the need for integrated paediatric fever management for appropriate treatment. |
|
|
|
|
An Estimated Four Billion Lack Access to Safe Drinking Water |
|
More than half of the global population is estimated to lack safe drinking water services in a study published in the journal Science. The results are depicted on a map that researchers compiled using machine learning based on data from household surveys and from earth observations. The study was led by the Swiss Federal Institute of Aquatic Science and Technology (Eawag) and supported by Swiss TPH, WHO, UNICEF and ETH Zurich. |
|
|
|
|
|
Emodepside Effective against Parasitic Worm Infections |
|
Researchers at Swiss TPH have demonstrated that the novel drug candidate, emodepside, is highly effective in treating parasitic worm infections in humans, particularly hookworms. The results of a Phase 2b trial confirmed the drug's strong efficacy and safety profile, building on the promising outcomes of an earlier Phase 2a study. Swiss TPH is collaborating with Bayer to further develop emodepside and fill the empty anthelmintic pipeline. |
|
|
|
|
Improved HIV Treatment for Children and Adolescents |
|
Globally, around 2.6 million children and adolescents are living with HIV, with the majority of them residing in sub-Saharan Africa. These young people are more likely to fail treatment than adults. While experts have long assumed that testing for viral drug resistance could improve treatment, a research team from the University of Basel, with Swiss TPH and partners, now shows that supporting patients in taking their medication regularly is far more important. |
|
|
|
|
Strengthening Swiss-Ivorian Research Partnership |
|
|
Empowering Communities through Nutrition |
|
|
Eliminating Schistosomiasis in Zanzibar |
|
|
Turning a Shipping Container into a Clinical Trial Site |
|
|
Warm Welcome to Our New Students |
|
|
At the start of the autumn semester, Swiss TPH welcomed 58 new students from many countries to our bachelor’s, master’s, PhD and postgraduate programmes. » Read more |
|
|
Health Care and Management: From Research to Implementation |
|
|
Gain core skills to understand and address global health challenges that will enable you to excel as a public health professional in resource-constrained settings. You will benefit from engagement with experts from a range of fields, practical application and interactive training. The course can be taken full-time over 14 weeks or modularly over 2-3 years.» Apply by 31 December 2024 |
|
|
Deepen Your Knowledge with Our Short Courses |
|
|
Health in Detention: Gain the information, methods and tools you need to analyse and address health and human rights issues affecting people in detention. » Apply by 15 October 2024 |
|
|
Travellers' Health: Equip yourself with the knowledge and skills needed to provide comprehensive health information, assess travel-related issues and effectively manage tropical diseases. » Apply by 10 December 2024 |
|
|
Good Clinical Practice Training: Our GCP training and refresher courses, accredited by Swissethics, provide a comprehensive overview of the ICH-GCP guidelines with a focus on human subject protection, informed consent, safety reporting, study design and submission to ethics committees in Switzerland. » Apply now |
|
|
Empowering Health Leaders |
|
Three of our DAS Health Care and Management alumni shared their experiences and the invaluable lessons they've learned during their time at Swiss TPH, illustrating the impact of mutual learning and the crucial role of scholarships. » Read more |
|
|
20 November 2024, Swiss TPH Symposium: Women and Gender in Global Health » Register now |
|
|
• |
Science: New, scientist-run virus database vows to be transparently run and simple to use » Article |
|
|
• |
SRF Wissen: Wann kann Afrika beginnen, gegen Mpox zu impfen? » Article |
|
|
• |
SRF Musik für einen Gast: Nicole Probst-Hensch – Epidemiologin, Forscherin, Biobankerin » Audio |
|
|
In our People of Swiss TPH Summer Special, we featured staff from our local offices: Meet Annie Maganga d'Almeida in Senegal, Olha Kostetska in Ukraine, Fekrije Hasani in Kosovo, Mohammad Firas Al Dali in Syria and Clementine Tumukunde in Rwanda. » Read more |
|
|
• |
Nyawanda B O, Khagayi S, Obor D et al. The effects of climatic and non-climatic factors on malaria mortality at different spatial scales in western Kenya, 2008–2019. BMJ Global Health » Read full article |
|
|
• |
Bosman S, Ayakaka I, Muhairwe J et al. Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa. Clinical Infectious Diseases » Read full article |
|
|
|
|
|